Synuclere

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSynuclere
Drug Alias Namealpha-synuclein therapeutic program (ProteoTech/ GSK)Parkinson's disease therapy (ProteoTech)PD-82PD-61-W3
ClassificationSmall molecules
Mechanisms of ActionSynuclein alpha inhibitorsNeuroprotectants
TargetsSynuclein alpha
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProteotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A